Daniel Brown
Last active: 4/26/2016

Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up.

Ho CK, Chapman WC, Brown DB
J Vasc Interv Radiol. 2007 18 (11): 1451-3

PMID: 18003999 · DOI:10.1016/j.jvir.2007.07.017

Orthotopic liver transplantation is frequently performed for patients with end-stage liver disease complicated by the development of small hepatocellular carcinomas (HCCs). Since the adaptation of the Milan criteria, the rate of posttransplantation recurrence has significantly decreased to a rate of 10%-20%. In the setting of recurrence after transplantation, survival rates are poor, with a median of 9 months. Survival can be extended with use of definitive therapies, most often surgical. The present report describes a patient with recurrent intrahepatic HCC after liver transplantation who was treated with radiofrequency ablation and has survived 24 months with normalization of alpha-fetoprotein levels and no evidence of viable tumor on imaging.

MeSH Terms (11)

Aged Carcinoma, Hepatocellular Catheter Ablation Follow-Up Studies Humans Liver Neoplasms Liver Transplantation Male Neoplasm Recurrence, Local Radiography Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: